Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy

A search database study

Stephen J. Freedland, William B. Isaacs, Elizabeth A. Platz, Martha Kennedy Terris, William J. Aronson, Christopher L. Amling, Joseph C. Presti, Christopher J. Kane

Research output: Contribution to journalArticle

181 Citations (Scopus)

Abstract

Purpose: Prostate growth and differentiation are under androgenic control, and prior studies suggested that tumors that develop in hypogonadal men are more aggressive. We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP). Patients and Methods: We evaluated the association of prostate weight with pathologic tumor grade, positive surgical margins, extracapsular disease, and seminal vesicle invasion using logistic regression and with biochemical progression using Cox proportional hazards regression among 1,602 men treated with RP between 1988 and 2003 at five equal-access medical centers, which composed the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Results: In outcome prediction models including multiple predictor variables, it was found that the predictor variable of prostate weight was significantly inversely associated with the outcomes of high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .004), and biochemical progression (comparing prostate weight < 20 v ≥ 100 g: relative risk = 8.43; 95% CI, 2.9 to 24.0; P < .001). Similar associations were seen between preoperative transrectal ultrasound-measured prostate volume and high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .005), seminal vesicle invasion (P = .07), and biochemical progression (P = .06). Conclusion: Men with smaller prostates had more high-grade cancers and more advanced disease and were at greater risk of progression after RP. These results suggest that prostate size may be an important prognostic variable that should be evaluated for use pre- and postoperatively to predict biochemical progression.

Original languageEnglish (US)
Pages (from-to)7546-7554
Number of pages9
JournalJournal of Clinical Oncology
Volume23
Issue number30
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Prostatectomy
Prostate
Prostatic Neoplasms
Databases
Weights and Measures
Seminal Vesicles
Neoplasms
Cancer Care Facilities
Logistic Models
Growth
Margins of Excision

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy : A search database study. / Freedland, Stephen J.; Isaacs, William B.; Platz, Elizabeth A.; Terris, Martha Kennedy; Aronson, William J.; Amling, Christopher L.; Presti, Joseph C.; Kane, Christopher J.

In: Journal of Clinical Oncology, Vol. 23, No. 30, 01.01.2005, p. 7546-7554.

Research output: Contribution to journalArticle

Freedland, Stephen J. ; Isaacs, William B. ; Platz, Elizabeth A. ; Terris, Martha Kennedy ; Aronson, William J. ; Amling, Christopher L. ; Presti, Joseph C. ; Kane, Christopher J. / Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy : A search database study. In: Journal of Clinical Oncology. 2005 ; Vol. 23, No. 30. pp. 7546-7554.
@article{cdbba99de61e4ea3b8ea57c08a9786d7,
title = "Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study",
abstract = "Purpose: Prostate growth and differentiation are under androgenic control, and prior studies suggested that tumors that develop in hypogonadal men are more aggressive. We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP). Patients and Methods: We evaluated the association of prostate weight with pathologic tumor grade, positive surgical margins, extracapsular disease, and seminal vesicle invasion using logistic regression and with biochemical progression using Cox proportional hazards regression among 1,602 men treated with RP between 1988 and 2003 at five equal-access medical centers, which composed the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Results: In outcome prediction models including multiple predictor variables, it was found that the predictor variable of prostate weight was significantly inversely associated with the outcomes of high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .004), and biochemical progression (comparing prostate weight < 20 v ≥ 100 g: relative risk = 8.43; 95{\%} CI, 2.9 to 24.0; P < .001). Similar associations were seen between preoperative transrectal ultrasound-measured prostate volume and high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .005), seminal vesicle invasion (P = .07), and biochemical progression (P = .06). Conclusion: Men with smaller prostates had more high-grade cancers and more advanced disease and were at greater risk of progression after RP. These results suggest that prostate size may be an important prognostic variable that should be evaluated for use pre- and postoperatively to predict biochemical progression.",
author = "Freedland, {Stephen J.} and Isaacs, {William B.} and Platz, {Elizabeth A.} and Terris, {Martha Kennedy} and Aronson, {William J.} and Amling, {Christopher L.} and Presti, {Joseph C.} and Kane, {Christopher J.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1200/JCO.2005.05.525",
language = "English (US)",
volume = "23",
pages = "7546--7554",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "30",

}

TY - JOUR

T1 - Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy

T2 - A search database study

AU - Freedland, Stephen J.

AU - Isaacs, William B.

AU - Platz, Elizabeth A.

AU - Terris, Martha Kennedy

AU - Aronson, William J.

AU - Amling, Christopher L.

AU - Presti, Joseph C.

AU - Kane, Christopher J.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Purpose: Prostate growth and differentiation are under androgenic control, and prior studies suggested that tumors that develop in hypogonadal men are more aggressive. We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP). Patients and Methods: We evaluated the association of prostate weight with pathologic tumor grade, positive surgical margins, extracapsular disease, and seminal vesicle invasion using logistic regression and with biochemical progression using Cox proportional hazards regression among 1,602 men treated with RP between 1988 and 2003 at five equal-access medical centers, which composed the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Results: In outcome prediction models including multiple predictor variables, it was found that the predictor variable of prostate weight was significantly inversely associated with the outcomes of high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .004), and biochemical progression (comparing prostate weight < 20 v ≥ 100 g: relative risk = 8.43; 95% CI, 2.9 to 24.0; P < .001). Similar associations were seen between preoperative transrectal ultrasound-measured prostate volume and high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .005), seminal vesicle invasion (P = .07), and biochemical progression (P = .06). Conclusion: Men with smaller prostates had more high-grade cancers and more advanced disease and were at greater risk of progression after RP. These results suggest that prostate size may be an important prognostic variable that should be evaluated for use pre- and postoperatively to predict biochemical progression.

AB - Purpose: Prostate growth and differentiation are under androgenic control, and prior studies suggested that tumors that develop in hypogonadal men are more aggressive. We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP). Patients and Methods: We evaluated the association of prostate weight with pathologic tumor grade, positive surgical margins, extracapsular disease, and seminal vesicle invasion using logistic regression and with biochemical progression using Cox proportional hazards regression among 1,602 men treated with RP between 1988 and 2003 at five equal-access medical centers, which composed the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Results: In outcome prediction models including multiple predictor variables, it was found that the predictor variable of prostate weight was significantly inversely associated with the outcomes of high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .004), and biochemical progression (comparing prostate weight < 20 v ≥ 100 g: relative risk = 8.43; 95% CI, 2.9 to 24.0; P < .001). Similar associations were seen between preoperative transrectal ultrasound-measured prostate volume and high-grade disease, positive surgical margins, extracapsular extension (all P ≤ .005), seminal vesicle invasion (P = .07), and biochemical progression (P = .06). Conclusion: Men with smaller prostates had more high-grade cancers and more advanced disease and were at greater risk of progression after RP. These results suggest that prostate size may be an important prognostic variable that should be evaluated for use pre- and postoperatively to predict biochemical progression.

UR - http://www.scopus.com/inward/record.url?scp=85047699965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047699965&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.05.525

DO - 10.1200/JCO.2005.05.525

M3 - Article

VL - 23

SP - 7546

EP - 7554

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 30

ER -